GLP-1 reduces metalloproteinase-9 induced by both hyperglycemia and hypoglycemia in type 1 diabetes. The possible role of oxidative stress

Antonio Ceriello1 Institut d’Investigación Biomédiques August Pi i Sunyer (IDIBAPS), Hospital Clinic, Barcelona, Spain;2 Centro de Investigación Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM), Hospital Clinic, Barcelona, SpainCorrespondence[email protected]

Lucia La Sala1 Institut d’Investigación Biomédiques August Pi i Sunyer (IDIBAPS), Hospital Clinic, Barcelona, Spain

Valeria De Nigris1 Institut d’Investigación Biomédiques August Pi i Sunyer (IDIBAPS), Hospital Clinic, Barcelona, Spain

Gemma Pujadas1 Institut d’Investigación Biomédiques August Pi i Sunyer (IDIBAPS), Hospital Clinic, Barcelona, Spain

Maurizio Rondinelli3 Department of Cardiovascular and Metabolic Diseases, IRCCS Gruppo Multimedica, Sesto San Giovanni (MI), Italy

Stefano Genovese3 Department of Cardiovascular and Metabolic Diseases, IRCCS Gruppo Multimedica, Sesto San Giovanni (MI), Italy

GLP-1 reduces metalloproteinase-9 induced by both hyperglycemia and hypoglycemia in type 1 diabetes. The possible role of oxidative stress

Information for

Open access

Opportunities

Help and information

GLP-1 reduces metalloproteinase-9 induced by both hyperglycemia and hypoglycemia in type 1 diabetes. The possible role of oxidative stress

Disclosure

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature